Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow fever
about
Historical Perspectives on Flavivirus ResearchMVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 virusesPlasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in miceSelection of recombinant MVA by rescue of the essential D4R gene.Bolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola VaccineModified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation.Experimental therapies for yellow feverVaccines for viral hemorrhagic fevers--progress and shortcomingsAdvances and controversies in yellow fever vaccinationCurrent status and future prospects of yellow fever vaccines.Genetic Adjuvantation of Recombinant MVA with CD40L Potentiates CD8 T Cell Mediated Immunity.Boosting with recombinant MVA expressing M. tuberculosis α-crystallin antigen augments the protection imparted by BCG against tuberculosis in guinea pigs.
P2860
Q29994534-63198589-28D2-454D-B6F0-80B216450D4EQ30358935-5D4FD69B-B8F1-4EA1-9D54-2BFD3DAE3E40Q34615061-59B5355C-CED0-42B6-853E-CA628DC080B2Q35800430-C29A1626-379C-400C-A43E-76EA7BD89C2BQ35917496-DA4F4E0C-8800-45F1-B389-54F678FCA0E5Q35943471-AEAF0BAF-D712-4BB0-ABA4-1575A36DC89EQ36586306-C921D72C-99F3-401B-8BDC-93BF34405A75Q37096221-8D98209B-BCE4-4A20-8533-F4743C3B0B29Q37709619-ABB28AC5-91C8-4372-B735-EBD6E0D483BBQ38586294-F0168C1D-74A6-4E8B-9F8F-231E85584D3BQ41822355-1A84C99B-7452-4927-98CE-F76F5505C55DQ47155139-77140E1C-2707-46F5-8CB7-D3B69BFAA1BD
P2860
Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow fever
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pre-clinical efficacy and safe ...... a vectors against yellow fever
@ast
Pre-clinical efficacy and safe ...... a vectors against yellow fever
@en
Pre-clinical efficacy and safe ...... a vectors against yellow fever
@nl
type
label
Pre-clinical efficacy and safe ...... a vectors against yellow fever
@ast
Pre-clinical efficacy and safe ...... a vectors against yellow fever
@en
Pre-clinical efficacy and safe ...... a vectors against yellow fever
@nl
prefLabel
Pre-clinical efficacy and safe ...... a vectors against yellow fever
@ast
Pre-clinical efficacy and safe ...... a vectors against yellow fever
@en
Pre-clinical efficacy and safe ...... a vectors against yellow fever
@nl
P2093
P2860
P1433
P1476
Pre-clinical efficacy and safe ...... a vectors against yellow fever
@en
P2093
Alexandra Joachimsthaler
Birgit Schäfer
Brian A Crowe
Falko G Falkner
Georg W Holzer
Michael Schwendinger
P Noel Barrett
Sogue Coulibaly
Thomas R Kreil
P2860
P304
P356
10.1371/JOURNAL.PONE.0024505
P407
P577
2011-01-01T00:00:00Z